Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65–70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM,

Alain Delmer, MD, Olivier Tournilhac, MD, PhD, Stéphane Leprêtre, MD, Bruno Cazin, MD, Pierre Feugier, MD, PhD, Brigitte Dreyfus, MD, Beatrice Mahe, Michel Leporrier, MD, Anne-Sophie Michallet, MD, Arnaud Jaccard, Marine Divine, MD, Vincent Levy, MD, Florence Cymbalista, Pr, Remi Letestu, MD

Blood (2011) 118 (21): 3900.

https://doi.org/10.1182/blood.V118.21.3900.3900

Published: 2011

Journal Articles

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Blood (2011) 117 (23): 6109–6119.

https://doi.org/10.1182/blood-2010-11-317073

Published: 2011

Journal Articles

Ancestim (r-metHuSCF) Plus Filgrastim for the Mobilization and Collection of Peripheral Blood Progenitor Cells for Autologous Transplant after Failure of Prior Mobilization: The French Experience of Compassionate Use.

Valerie Lapierre, MD, PhD, Christian Chabannon, MD, Caroline Makowski, MD, Cecile Dumesnil, MD, Dominique Valteau-Couanet, MD, PhD, Anne Vekhoff, MD, Denis Caillot, MD, Nabih Azar, MD, Marine Divine, MD, Karin Blakolmer, MD, Christian Cailliot, MD, Philippe Moreau, MD, PhD, Jean-Francois Rossi, MD, PhD

Blood (2007) 110 (11): 3281.

https://doi.org/10.1182/blood.V110.11.3281.3281

Published: 2007

Journal Articles

Dexamethasone+Thalidomide (Dex/Thal) Compared to VAD as a Pre-Transplant Treatment in Newly Diagnosed Multiple Myeloma (MM): A Randomized Trial.

Margaret Macro, MD, Marine Divine, M.D., Yurdagul Uzunhan, M.D., Arnaud Jaccard, M.D., Didier Bouscary, M.D., Veronique Leblond, M.D., Maud Janvier, M.D., Philippe Genet, M.D., Sylvie Castaigne, M.D., Bruno Royer, M.D., Christian Allard, M.D., Sylvie Chevret, M.D., Jean-Paul Fermand, M.D.

Blood (2006) 108 (11): 57.

https://doi.org/10.1182/blood.V108.11.57.57

Published: 2006

Journal Articles

Consolidation Therapy with Subcutaneous Alemtuzumab Following Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65-70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): A Phase II Trial of the FCGCLL/MW.

Alain Delmer, MD, Stéphane Leprêtre, MD, Bruno Cazin, MD, Pierre Feugier, MD, PhD, Olivier Tournilhac, MD, PhD, Michel Leporrier, MD, Brigitte Dreyfus, MD, Béatrice Mahé, MD, Catherine Thieblemont, MD, PhD, Marine Divine, MD, Vincent Lévy, MD, PhD, Véronique Leblond, MD, Florence Cymbalista, MD, PhD, Rémy Letestu, MD, PhD

Blood (2006) 108 (11): 2831.

https://doi.org/10.1182/blood.V108.11.2831.2831

Published: 2006

Journal Articles

A Randomized Comparison of Dexamethasone + Thalidomide (Dex/Thal) vs Dex + Placebo (Dex/P) in Patients (pts) with Relapsing Multiple Myeloma (MM).

Jean-Paul Fermand, MD, Arnaud Jaccard, M.D., Margaret Macro, M.D., Yurdagul Uzunhan, M.D., Christian Allard, M.D., Sylvie Castaigne, M.D., Marine Divine, M.D., Xavier Mariette, M.D., Veronique Leblond, M.D., Sylvie Chevret, M.D.

Blood (2006) 108 (11): 3563.

https://doi.org/10.1182/blood.V108.11.3563.3563

Published: 2006

Journal Articles

Pharmacogenetic Study in Hodgkin’s Lymphomas, Impact of UGT1A1 on Prognosis.

Vincent Ribrag, MD, Serge Koscielny, phD, Olivier Casasnovas, MD, Cecile Cazeneuve, MD, phD, Pauline Brice, MD, Franck Morschhauser, MD, Jean Gabarre, MD, Marine Divine, MD, Laurent Voillat, MD, Apasia Stamatoullas, MD, Gilbert Lenoir, phD, Gilles Andre Salles, MD, phD

Blood (2006) 108 (11): 2266.

https://doi.org/10.1182/blood.V108.11.2266.2266

Published: 2006

Journal Articles

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Christophe Fermé, Nicolas Mounier, Olivier Casasnovas, Pauline Brice, Marine Divine, Anne Sonet, Fahdela Bouafia, Aspasia Bastard-Stamatoullas, Dominique Bordessoule, Laurent Voillat, Oumedaly Reman, Michel Blanc, Christian Gisselbrecht, for the Groupe d'Etude des Lymphomes de l'Adulte

Blood (2006) 107 (12): 4636–4642.

https://doi.org/10.1182/blood-2005-11-4429

Published: 2006

Journal Articles

Rituximab in Combination with CHOP Regimen in Angioimmunoblastic T-Cell Lymphoma (AITL). Preliminary Results in 9 Patients Treated in a Single Institution.

Bertrand Joly, Valerie Frenkel, Philippe Gaulard, Karim Belhadj, Taoufik El Gnaoui, Jehan Dupuis, Marine Divine, Alain Rahmouni, Christiane Copie Bergman, Marie Helene Delfau-Larue, Felix Reyes, Corinne Haioun

Blood (2005) 106 (11): 2686.

https://doi.org/10.1182/blood.V106.11.2686.2686

Published: 2005

Journal Articles

Impaired Mobilization of Peripheral Blood Stem Cell (PBSC) after Fludarabine Treatment: Comparison of Results Using 3 Different Procedures.

Philippe Genet, MD, Philippe Travade, MD, Bruno Cazin, MD, Stephane Lepretre, MD, Marine Divine, MD, Claude Martin, MD, Veronique Leblond, MD, Eric Van Den Neste, MD, Frederic Maloisel, MD, Mauricette Michallet, MD, Houchingue Eghbali, MD, Christian Berthou, MD, Alain Delmer, MD, Bernard Grosbois, MD, Pierre Feugier, MD, Michel Leporrier, MD, Laurent Sutton, MD, Olivier Tournilhac, MD

Blood (2005) 106 (11): 1978.

https://doi.org/10.1182/blood.V106.11.1978.1978

Published: 2005

Journal Articles

Single or Tandem Autologous Stem-Cell Transplantation Given According to Prognostic Factors at Relapse for Hodgkin Lymphoma.

Pauline Brice, MD, Franck Morschhauser, MD, Marine Divine, MD, Christophe Ferme, MD, Gilles Salles, MD, PD

Blood (2005) 106 (11): 2069.

https://doi.org/10.1182/blood.V106.11.2069.2069

Published: 2005

Journal Articles

Blood Flow Cytometry Allows Us To Dispense with Bone Marrow Biopsy in the Evaluation of Treatment Response in CLL.

Karim Maloum, MDPhD, Frederic Charlotte, MD, Marine Divine, MD, Bruno Cazin, MD, Stephane Lepretre, MD, Alain Delmer, MD, Sylvie Sonneville, Helene Merle-Beral, MDPhD

Blood (2004) 104 (11): 4769.

https://doi.org/10.1182/blood.V104.11.4769.4769

Published: 2004

Journal Articles

Prognostic Factors in Localized Hodgkin’s Lymphoma: How To Define Intermediate/Unfavourable Disease?.

Christian Gisselbrecht, Nicolas Mounier, Olivier Casanovas, O. Reman, Catherine Sebban, Marine Divine, Pauline Brice, Josette Briere, Christophe Hennequin, Pierre Feugier, Christophe Ferme

Blood (2004) 104 (11): 3122.

https://doi.org/10.1182/blood.V104.11.3122.3122

Published: 2004

Journal Articles

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Michel Leporrier, Sylvie Chevret, Bruno Cazin, Najda Boudjerra, Pierre Feugier, Bernard Desablens, Marie-José Rapp, Jerome Jaubert, Claudie Autrand, Marine Divine, Brigitte Dreyfus, Karim Maloum, Philippe Travade, Guillaume Dighiero, Jacques-Louis Binet, Claude Chastang

Blood (2001) 98 (8): 2319–2325.

https://doi.org/10.1182/blood.V98.8.2319

Published: 2001

Journal Articles

High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial

Jean-Paul Fermand, Philippe Ravaud, Sylvie Chevret, Marine Divine, Véronique Leblond, Coralie Belanger, Margaret Macro, Edouard Pertuiset, François Dreyfus, Xavier Mariette, Catherine Boccacio, Jean-Claude Brouet

Blood (1998) 92 (9): 3131–3136.

https://doi.org/10.1182/blood.V92.9.3131

Published: 1998

NARROW

Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65–70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM,

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Ancestim (r-metHuSCF) Plus Filgrastim for the Mobilization and Collection of Peripheral Blood Progenitor Cells for Autologous Transplant after Failure of Prior Mobilization: The French Experience of Compassionate Use.

Dexamethasone+Thalidomide (Dex/Thal) Compared to VAD as a Pre-Transplant Treatment in Newly Diagnosed Multiple Myeloma (MM): A Randomized Trial.

Consolidation Therapy with Subcutaneous Alemtuzumab Following Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65-70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): A Phase II Trial of the FCGCLL/MW.

A Randomized Comparison of Dexamethasone + Thalidomide (Dex/Thal) vs Dex + Placebo (Dex/P) in Patients (pts) with Relapsing Multiple Myeloma (MM).

Pharmacogenetic Study in Hodgkin’s Lymphomas, Impact of UGT1A1 on Prognosis.

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Rituximab in Combination with CHOP Regimen in Angioimmunoblastic T-Cell Lymphoma (AITL). Preliminary Results in 9 Patients Treated in a Single Institution.

Impaired Mobilization of Peripheral Blood Stem Cell (PBSC) after Fludarabine Treatment: Comparison of Results Using 3 Different Procedures.

Single or Tandem Autologous Stem-Cell Transplantation Given According to Prognostic Factors at Relapse for Hodgkin Lymphoma.

Blood Flow Cytometry Allows Us To Dispense with Bone Marrow Biopsy in the Evaluation of Treatment Response in CLL.

Prognostic Factors in Localized Hodgkin’s Lymphoma: How To Define Intermediate/Unfavourable Disease?.

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only